Literature DB >> 20199501

Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry.

B W Gillespie1, R M Merion, E Ortiz-Rios, L Tong, A Shaked, R S Brown, A O Ojo, P H Hayashi, C L Berg, M M Abecassis, A S Ashworth, C E Friese, J C Hong, J F Trotter, J E Everhart.   

Abstract

Data submitted by transplant programs to the Organ Procurement and Transplantation Network (OPTN) are used by the Scientific Registry of Transplant Recipients (SRTR) for policy development, performance evaluation and research. This study compared OPTN/SRTR data with data extracted from medical records by research coordinators from the nine-center A2ALL study. A2ALL data were collected independently of OPTN data submission (48 data elements among 785 liver transplant candidates/recipients; 12 data elements among 386 donors). At least 90% agreement occurred between OPTN/SRTR and A2ALL for 11/29 baseline recipient elements, 4/19 recipient transplant or follow-up elements and 6/12 donor elements. For the remaining recipient and donor elements, >10% of values were missing in OPTN/SRTR but present in A2ALL, confirming that missing data were largely avoidable. Other than variables required for allocation, the percentage missing varied widely by center. These findings support an expanded focus on data quality control by OPTN/SRTR for a broader variable set than those used for allocation. Center-specific monitoring of missing values could substantially improve the data.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199501      PMCID: PMC2907466          DOI: 10.1111/j.1600-6143.2010.03039.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  17 in total

1.  Transplant data: sources, collection and research considerations, 2004.

Authors:  David M Dickinson; Dawn M Dykstra; Gregory N Levine; Shiqian Li; James C Welch; Randall L Webb
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

2.  Immunosuppression: evolution in practice and trends, 1993-2003.

Authors:  Ron Shapiro; James B Young; Edgar L Milford; James F Trotter; Rami T Bustami; Alan B Leichtman
Journal:  Am J Transplant       Date:  2005-04       Impact factor: 8.086

3.  Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey.

Authors:  Paula M Stirnemann; Steven K Takemoto; Mark A Schnitzler; Daniel C Brennan; Kevin C Abbott; Paolo Salvalaggio; Thomas E Burroughs; Jeffrey A Gavard; Lisa M Willoughby; Krista L Lentine
Journal:  J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 10.121

4.  Analytical methods and database design: implications for transplant researchers, 2005.

Authors:  G N Levine; K P McCullough; A M Rodgers; D M Dickinson; V B Ashby; D E Schaubel
Journal:  Am J Transplant       Date:  2006       Impact factor: 8.086

5.  Linking the US transplant registry to administrative claims data: expanding the potential of transplant research.

Authors:  Amanda S Gilmore; J Harold Helderman; Jean-Francois Ricci; Kira L Ryskina; Sandy Feng; Ning Kang; Antonio P Legorreta
Journal:  Med Care       Date:  2007-06       Impact factor: 2.983

Review 6.  A critical look at methods for handling missing covariates in epidemiologic regression analyses.

Authors:  S Greenland; W D Finkle
Journal:  Am J Epidemiol       Date:  1995-12-15       Impact factor: 4.897

7.  Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.

Authors:  Kim M Olthoff; Robert M Merion; Rafik M Ghobrial; Michael M Abecassis; Jeffrey H Fair; Robert A Fisher; Chris E Freise; Igal Kam; Timothy L Pruett; James E Everhart; Tempie E Hulbert-Shearon; Brenda W Gillespie; Jean C Emond
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

8.  Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients.

Authors:  R H Wiesner; B J Steffen; K M David; A H Chu; R D Gordon; J R Lake
Journal:  Am J Transplant       Date:  2006-07       Impact factor: 8.086

9.  Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C.

Authors:  Russell H Wiesner; Jolene S Shorr; Bettina J Steffen; Alice H Chu; Robert D Gordon; John R Lake
Journal:  Liver Transpl       Date:  2005-07       Impact factor: 5.799

Review 10.  Improving liver allocation: MELD and PELD.

Authors:  Richard B Freeman; Russell H Wiesner; John P Roberts; Suzanne McDiarmid; Dawn M Dykstra; Robert M Merion
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

View more
  21 in total

1.  Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation.

Authors:  Brett E Fortune; Alvaro Martinez-Camacho; Sarah Kreidler; Jane Gralla; Gregory T Everson
Journal:  Transpl Int       Date:  2015-04-16       Impact factor: 3.782

Review 2.  Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research.

Authors:  Zeeshan Butt; Neehar D Parikh; Anton I Skaro; Daniela Ladner; David Cella
Journal:  Curr Opin Organ Transplant       Date:  2012-06       Impact factor: 2.640

3.  Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States.

Authors:  N H Urrunaga; V P Rachakonda; L S Magder; A L Mindikoglu
Journal:  Transplant Proc       Date:  2014 Jan-Feb       Impact factor: 1.066

4.  Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation.

Authors:  Cynthia Tsien; Ari Garber; Arvind Narayanan; Shetal N Shah; David Barnes; Bijan Eghtesad; John Fung; Arthur J McCullough; Srinivasan Dasarathy
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

5.  Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience.

Authors:  Kim M Olthoff; Michael M Abecassis; Jean C Emond; Igal Kam; Robert M Merion; Brenda W Gillespie; Lan Tong
Journal:  Liver Transpl       Date:  2011-07       Impact factor: 5.799

6.  Live liver donors' risk thresholds: risking a life to save a life.

Authors:  Michele Molinari; Jacob Matz; Sarah DeCoutere; Karim El-Tawil; Bassam Abu-Wasel; Valerie Keough
Journal:  HPB (Oxford)       Date:  2013-11-20       Impact factor: 3.647

7.  How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology?

Authors:  Marco Carbone; Jan Lerut; James Neuberger
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

8.  Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.

Authors:  Josh Levitsky; David Goldberg; Abigail R Smith; Sarah A Mansfield; Brenda W Gillespie; Robert M Merion; Anna S F Lok; Gary Levy; Laura Kulik; Michael Abecassis; Abraham Shaked
Journal:  Clin Gastroenterol Hepatol       Date:  2016-08-25       Impact factor: 11.382

Review 9.  Program-specific reports: implications and impact on program behavior.

Authors:  Lisa B VanWagner; Anton I Skaro
Journal:  Curr Opin Organ Transplant       Date:  2013-04       Impact factor: 2.640

10.  Defining long-term outcomes with living donor liver transplantation in North America.

Authors:  Kim M Olthoff; Abigail R Smith; Michael Abecassis; Talia Baker; Jean C Emond; Carl L Berg; Charlotte A Beil; James R Burton; Robert A Fisher; Chris E Freise; Brenda W Gillespie; David R Grant; Abhinav Humar; Igal Kam; Robert M Merion; Elizabeth A Pomfret; Benjamin Samstein; Abraham Shaked
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.